Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
News Focus
Numinus Wellness Focused on Boosting Profitability and Expanding Community Support (click to learn more)
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Pharmather Holdings Ltd
C.PHRM
Alternate Symbol(s):
PHRRF
psychedelics
PharmaTher Holdings Ltd. is a Canada-based specialty pharmaceutical company. The Company develops and commercializes specialty pharmaceuticals exhibiting growing adoption and permitting delivery methods to enhance patient outcomes. Its lead product is KETARX (racemic ketamine) to fill the global unmet medical needs for anesthesia, sedation, pain, mental health, and neurological indications. The...
Company is also commercializing PharmaPatch (microneedle patch) with its partners to deliver psychedelics and drugs to treat infectious diseases.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (CSE:PHRM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 18, 2024 4:00pm
New Press Release - PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
TORONTO, April 18, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, today announced receipt of a Complete Response Letter (“CRL”) for its Priority Original Abbreviated New Drug Application (“ANDA...
read article.
(1)
•••
Glloyd
X
View Profile
View Bullboard History
Post by
Glloyd
on Apr 17, 2024 3:25pm
It’s sure taking its time!
With only 11 days left before @possibly FDA , I think the stock would at least rise another $.20-$.25 before FDA So I would think next week you@ll see increases every day I would hope I'll
...more
CLOUD DX Signs Multi-Year Contract with Provincial Health Authority
posted May 07, 2024 9:00am by
Cloud DX Inc.
-
|
The company is pleased to announce the execution on April 23, 2024 of a Remote Patient Monitoring Agreement for Cloud DX RPM Services with a Canadian Provincial Health Authority. This agreement is the 4th Provincial Health Authority contract for Cloud DX remote patient monitoring (RPM) services, alongside Alberta, the Yukon and Prince Edward Island. The contract has a term of 36 months with 2 extensions of 12 months each. The average contract value of each individual subscription is expected to be approximately ...read more
(1)
•••
Glloyd
X
View Profile
View Bullboard History
Post by
Glloyd
on Apr 17, 2024 1:38pm
It’s sure taking its time!
With only 11 days left before possibly FDA , I think the stock would at least rise another $.20-$.25 before FDA So I would think next week you'll see increases every day I would hope I guess
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 16, 2024 8:00am
New Press Release - PharmaTher Provides Update of its Priority Original Abbreviated New Drug Application for Ketamine
TORONTO, April 16, 2024 (GLOBE NEWSWIRE) -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a specialty pharmaceutical company, provides an update of its Priority Original Abbreviated New Drug Application (“ANDA”) for Ketamine that was accepted by the U.S...
read article.
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Apr 13, 2024 3:15pm
RE:Bigger exchange
FDA is just the first step, obviously a very necessary one. Company still has to execute sales, partnerships etc. Nasdaq wouldnt make sense untill they can start realizing income from their product
...more
(28)
•••
Sailormark
X
View Profile
View Bullboard History
Post by
Sailormark
on Apr 13, 2024 12:27pm
Bigger exchange
With FDA approval with this stock move to a bigger exchange.? NASDAQ?
(456)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Post by
TheLandedEagles
on Apr 13, 2024 9:58am
Bottomed Out..re-loading and buyers back in for NEXT Move UP
Only time before we get FDA approval news..while last 3-4 days have seen a sell off price drop of 50% or one can also may say an occurring "accumulation"...presently without any negative
...more
(456)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Comment by
TheLandedEagles
on Apr 11, 2024 10:30am
RE:13 trading days left !
Well said..couldn't agree more. Great chance KETRAX gets approved and then here in Canada and around the world. Huge revenues to come thereafter. Bought more myself yesterday. Its a good
...more
(10)
•••
BradlTheGerman
X
View Profile
View Bullboard History
Post by
BradlTheGerman
on Apr 11, 2024 2:45am
13 trading days left !
I very much doubt that there is a leak from the FDA. Fear, doubt, nervousness, uncertainty and unprofessionalism have characterized the last 2 trading days. Those who sell realize a
...more
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Comment by
Itistoo
on Apr 10, 2024 6:52pm
RE:No reason to be nervous !
More than stop losses here, heavy selling the past 2 days completely wiped out all of marches gains. Could be a coordinated efford to shake out some nervous hands. Also possible there was a leak and
...more
(10)
•••
BradlTheGerman
X
View Profile
View Bullboard History
Post by
BradlTheGerman
on Apr 10, 2024 2:57am
No reason to be nervous !
To be honest, I'm not worried about the fall in prices. It was clear to me that attempts would be made to fish out stop losses and force nervous small investors (paper hands) out of the market.
...more
(8)
•••
Itistoo
X
View Profile
View Bullboard History
Post by
Itistoo
on Apr 10, 2024 12:20am
Melt down
Yikes.. tomorrow will be a telling day but volume dried up here last week and with this tank today looks like the teens are a possibility unless some buying support comes back here
(456)
•••
TheLandedEagles
X
View Profile
View Bullboard History
Post by
TheLandedEagles
on Apr 03, 2024 12:54pm
Nice..Just picked up 100K..@ .285 cents average...
Impatient holders...understandable, nervesness....its ok, risk needs strong stomachs!!! and strong convictions about the company..everyone is difference and has their own tolerance. We can only cross
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Apr 02, 2024 7:30am
New Press Release - Revive Therapeutics Provides Update on Psilocybin Clinical Study for Methamphetamine Use Disorder
TORONTO, April 02, 2024 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to provide an...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
NOI Filed for Drill Program at Lithium/Uranium Project in Nevada
Silvercorp to Acquire Adventus for Implied Consideration of C$0.50 per Share
Multiple High-Grade Gold Hits at the Tonopah Gold Project Including 90 Meters at 2.0 gpt Gold
Meet one of the Strongest Contenders to Lead Canada’s Cannabis Market
A Leading Provider in Virtual Healthcare Adds 4th Provincial Health Authority Contract